Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1015

1.

Participation, Fear of Falling, and Upper Limb Impairment are Associated with High Sitting Time in People with Stroke.

Hanna E, Janssen H, Crowfoot G, Mason G, Vyslysel G, Sweetapple A, Callister R, English C.

Occup Ther Health Care. 2019 Mar 19:1-16. doi: 10.1080/07380577.2019.1587675. [Epub ahead of print]

PMID:
30890006
2.

Modulation of TAP-dependent antigen compartmentalization during human monocyte-to-DC differentiation.

Döring M, Blees H, Koller N, Tischer-Zimmermann S, Müsken M, Henrich F, Becker J, Grabski E, Wang J, Janssen H, Zuschratter W, Neefjes J, Klawonn F, Eiz-Vesper B, Tampé R, Kalinke U.

Blood Adv. 2019 Mar 26;3(6):839-850. doi: 10.1182/bloodadvances.2018027268.

3.

Peginterferon alfa-2a (40 kD) stopping rules in chronic hepatitis B: a systematic review and meta-analysis of individual participant data.

Pavlovic V, Yang L, Chan HL, Hou J, Janssen HL, Kao JH, Lampertico P, Peng CY, Piratvisuth T, Thompson AJ, Wedemeyer H, Wei L, Wat C.

Antivir Ther. 2019 Mar 13. doi: 10.3851/IMP3304. [Epub ahead of print]

PMID:
30865588
4.

Role of Autophagy in Chronic Liver Inflammation and Fibrosis.

Tseng YJ, Dong L, Xu N, Ma W, Weng SQ, Janssen HLA, Wu SD.

Curr Protein Pept Sci. 2019 Mar 5. doi: 10.2174/1389203720666190305165203. [Epub ahead of print]

PMID:
30843487
5.

Sustained off-treatment viral control is associated with high hepatitis B surface antigen seroclearance rates in Caucasian patients with nucleos(t)ide analogue-induced HBeAg seroconversion.

Van Hees S, Chi H, Hansen B, Bourgeois S, Van Vlierberghe H, Sersté T, Francque S, Wong D, Sprengers D, Moreno C, Nevens F, Janssen HLA, Vanwolleghem T.

J Viral Hepat. 2019 Feb 23. doi: 10.1111/jvh.13084. [Epub ahead of print] No abstract available.

PMID:
30801868
6.

Safety and efficacy of stopping tenofovir disoproxil fumarate in patients with chronic hepatitis B following at least 8 years of therapy: a prespecified follow-up analysis of two randomised trials.

Buti M, Wong DK, Gane E, Flisiak R, Manns M, Kaita K, Janssen HLA, Op den Brouw M, Jump B, Kitrinos K, Crans G, Flaherty J, Gaggar A, Marcellin P.

Lancet Gastroenterol Hepatol. 2019 Apr;4(4):296-304. doi: 10.1016/S2468-1253(19)30015-9. Epub 2019 Feb 20.

PMID:
30795958
7.

Editorial: identifying candidates for pegylated interferon add-on to entecavir therapy in patients with HBeAg-positive chronic hepatitis B - authors' reply.

Liem KS, Janssen HLA.

Aliment Pharmacol Ther. 2019 Mar;49(5):610-611. doi: 10.1111/apt.15155. No abstract available.

PMID:
30746771
8.

Association Between Severe Serum Alanine Aminotransferase Flares and Hepatitis B e Antigen Seroconversion and HBV DNA Decrease in Untreated Patients With Chronic HBV Infection.

Brahmania M, Lombardero M, Hansen BE, Terrault NA, Lok AS, Perrillo RP, Belle SH, Di Bisceglie AM, Feld JJ, Lee WM, Fried MW, Janssen HLA; Hepatitis B Research Network.

Clin Gastroenterol Hepatol. 2019 Feb 8. pii: S1542-3565(19)30143-0. doi: 10.1016/j.cgh.2019.02.005. [Epub ahead of print]

PMID:
30743006
9.

Breaking up sitting time after stroke - How much less sitting is needed to improve blood pressure after stroke (BUST-BP-Dose): Protocol for a dose-finding study.

Mackie P, Crowfoot G, Janssen H, Dunstan DW, Bernhardt J, Walker FR, Patterson A, Callister R, Spratt NJ, Holliday E, English C.

Contemp Clin Trials Commun. 2018 Dec 2;13:100310. doi: 10.1016/j.conctc.2018.100310. eCollection 2019 Mar.

10.

Genome Wide Association Study Identifies Genetic Variants Associated With Early And Sustained Response To (Peg)Interferon In Chronic Hepatitis B Patients: The GIANT-B Study.

Brouwer WP, Chan HL, Lampertico P, Hou J, Tangkijvanich P, Reesink HW, Zhang W, Mangia A, Tanwandee T, Montalto G, Simon K, Ormeci N, Chen L, Tabak F, Gunsar F, Flisiak R, Ferenci P, Akdogan M, Akyuz F, Hirankarn N, Jansen L, Wong Wai-Sun V, Soffredini R, Liang X, Chen S, Groothuismink ZM, Santoro R, Jaroszewicz J, Ozaras R, Kozbial K, Brahmania M, Xie Q, Chotiyaputta W, Xun Q, Pazgan-Simon M, Oztas E, Verhey E, Montanari NR, Sun J, Hansen BE, Boonstra A, Janssen H; GIANT-B Global Consortium.

Clin Infect Dis. 2019 Feb 2. doi: 10.1093/cid/ciz084. [Epub ahead of print]

PMID:
30715261
11.

Low hepatitis B surface antigen and HBV DNA levels predict response to the addition of pegylated interferon to entecavir in hepatitis B e antigen positive chronic hepatitis B.

Liem KS, van Campenhout MJH, Xie Q, Brouwer WP, Chi H, Qi X, Chen L, Tabak F, Hansen BE, Janssen HLA.

Aliment Pharmacol Ther. 2019 Feb;49(4):448-456. doi: 10.1111/apt.15098.

PMID:
30689258
12.

Synchronous fluorescence spectroscopy combined with chemometrics for rapid assessment of cold-pressed grape seed oil adulteration: Qualitative and quantitative study.

Karuk Elmas ŞN, Arslan FN, Akin G, Kenar A, Janssen HG, Yilmaz I.

Talanta. 2019 May 1;196:22-31. doi: 10.1016/j.talanta.2018.12.026. Epub 2018 Dec 12.

PMID:
30683355
13.

Molecular mechanisms of bleeding disorder-associated GFI1BQ287* mutation and its affected pathways in megakaryocytes and platelets.

van Oorschot R, Hansen M, Koornneef JM, Marneth AE, Bergevoet SM, van Bergen MGJM, van Alphen FPJ, van der Zwaan C, Martens JHA, Vermeulen M, Jansen PWTC, Baltissen MPA, Laros-van Gorkom BAP, Janssen H, Jansen JH, von Lindern M, Meijer AB, van den Akker E, van der Reijden BA.

Haematologica. 2019 Jan 17. pii: haematol.2018.194555. doi: 10.3324/haematol.2018.194555. [Epub ahead of print]

14.

Direct analysis of aromatic hydrocarbons in purified mineral oils for foods and cosmetics applications using gas chromatography with vacuum ultraviolet detection.

García-Cicourel AR, Janssen HG.

J Chromatogr A. 2019 Apr 12;1590:113-120. doi: 10.1016/j.chroma.2019.01.015. Epub 2019 Jan 8.

15.

Author Correction: Chemically triggered drug release from an antibody-drug conjugate leads to potent antitumour activity in mice.

Rossin R, Versteegen RM, Wu J, Khasanov A, Wessels HJ, Steenbergen EJ, Ten Hoeve W, Janssen HM, van Onzen AHAM, Hudson PJ, Robillard MS.

Nat Commun. 2019 Jan 16;10(1):363. doi: 10.1038/s41467-019-08376-x.

16.

Validation of a normal tissue complication probability model for late unfavourable aesthetic outcome after breast-conserving therapy.

Kindts I, Defraene G, Petillion S, Janssen H, Van Limbergen E, Depuydt T, Weltens C.

Acta Oncol. 2019 Jan 14:1-8. doi: 10.1080/0284186X.2018.1548775. [Epub ahead of print]

PMID:
30638097
17.

Improved Definition of HBV Phenotypes based on Genotype-specific Levels of Hepatitis B s Antigen.

Brouwer WP, Zhao Q, Hansen BE, Lau D, Khalili M, Terrault NA, Di Bisceglie AM, Perrillo RP, Fried MW, Wong D, Feld JJ, Belle SH, Janssen HLA; Hepatitis B Research Network (HBRN).

Clin Gastroenterol Hepatol. 2019 Jan 7. pii: S1542-3565(19)30012-6. doi: 10.1016/j.cgh.2018.12.039. [Epub ahead of print] No abstract available.

PMID:
30630104
18.

Effects of Age and Sex of Response to Ursodeoxycholic Acid and Transplant-free Survival in Patients With Primary Biliary Cholangitis.

Cheung AC, Lammers WJ, Murillo Perez CF, van Buuren HR, Gulamhusein A, Trivedi PJ, Lazaridis KN, Ponsioen CY, Floreani A, Hirschfield GM, Corpechot C, Mayo MJ, Invernizzi P, Battezzati PM, Parés A, Nevens F, Thorburn D, Mason AL, Carbone M, Kowdley KV, Bruns T, Dalekos GN, Gatselis NK, Verhelst X, Lindor KD, Lleo A, Poupon R, Janssen HL, Hansen BE; Global PBC Study Group.

Clin Gastroenterol Hepatol. 2019 Jan 4. pii: S1542-3565(19)30001-1. doi: 10.1016/j.cgh.2018.12.028. [Epub ahead of print]

PMID:
30616022
19.

A comparison of a brachytherapy and an external beam radiotherapy boost in breast-conserving therapy for breast cancer: local and any recurrences.

Kindts I, Verhoeven K, Laenen A, Christiaens M, Janssen H, Van der Vorst A, Van Limbergen E, Weltens C.

Strahlenther Onkol. 2019 Jan 2. doi: 10.1007/s00066-018-1413-0. [Epub ahead of print]

PMID:
30603857
20.

Activity Monitors for Increasing Physical Activity in Adult Stroke Survivors.

Lynch EA, Jones TM, Simpson DB, Fini NA, Kuys S, Borschmann K, Kramer S, Johnson L, Callisaya ML, Mahendran N, Janssen H, English C; ACTIOnS Collaboration.

Stroke. 2018 Nov 21:STROKEAHA118023088. doi: 10.1161/STROKEAHA.118.023088. [Epub ahead of print] No abstract available.

PMID:
30580734
21.

Cost Effectiveness of Hepatocellular Carcinoma Surveillance After a Sustained Virologic Response to Therapy in Patients With Hepatitis C Virus Infection and Advanced Fibrosis.

Farhang Zangneh H, Wong WWL, Sander B, Bell CM, Mumtaz K, Kowgier M, van der Meer AJ, Cleary SP, Janssen HLA, Chan KKW, Feld JJ.

Clin Gastroenterol Hepatol. 2018 Dec 20. pii: S1542-3565(18)31394-6. doi: 10.1016/j.cgh.2018.12.018. [Epub ahead of print]

PMID:
30580095
22.

Entecavir and Peginterferon Alfa-2a in Adults With Hepatitis B e Antigen-Positive Immune-Tolerant Chronic Hepatitis B Virus Infection.

Feld JJ, Terrault NA, Lin HS, Belle SH, Chung RT, Tsai N, Khalili M, Perrillo R, Cooper SL, Ghany MG, Janssen HLA, Lok AS; Hepatitis B Research Network.

Hepatology. 2018 Dec 14. doi: 10.1002/hep.30417. [Epub ahead of print]

PMID:
30549279
23.

Comparison of PED and FRED Flow Diverters for Internal Carotid Artery Aneurysms: A Propensity Score-Matched Cohort Study.

Griessenauer CJ, Thomas AJ, Enriquez-Marulanda A, Deshmukh A, Jain A, Ogilvy CS, Kocer N, Engelhorn T, Möhlenbruch M, Holtmannspötter M, Janssen H, Finkenzeller T, Reith W, Sonnberger M, Buhk JH, Schirmer CM, Killer-Oberpfalzer M.

Neurosurgery. 2018 Dec 12. doi: 10.1093/neuros/nyy572. [Epub ahead of print]

PMID:
30541114
24.

In vitro and in vivo accumulation of magnetic nanoporous silica nanoparticles on implant materials with different magnetic properties.

Janßen HC, Warwas DP, Dahlhaus D, Meißner J, Taptimthong P, Kietzmann M, Behrens P, Reifenrath J, Angrisani N.

J Nanobiotechnology. 2018 Nov 27;16(1):96. doi: 10.1186/s12951-018-0422-6.

25.

Remote Welfare Monitoring of Rodents Using Thermal Imaging.

Pereira CB, Kunczik J, Zieglowski L, Tolba R, Abdelrahman A, Zechner D, Vollmar B, Janssen H, Thum T, Czaplik M.

Sensors (Basel). 2018 Oct 28;18(11). pii: E3653. doi: 10.3390/s18113653.

26.

Regulatory aspects of the development of drugs for metabolic bone diseases - FDA and EMA perspective.

Kehoe T, Blind E, Janssen H.

Br J Clin Pharmacol. 2018 Oct 18. doi: 10.1111/bcp.13791. [Epub ahead of print] Review.

PMID:
30335197
27.

Mechanisms of integrin αVβ5 clustering in flat clathrin lattices.

Zuidema A, Wang W, Kreft M, Te Molder L, Hoekman L, Bleijerveld OB, Nahidiazar L, Janssen H, Sonnenberg A.

J Cell Sci. 2018 Nov 5;131(21). pii: jcs221317. doi: 10.1242/jcs.221317.

PMID:
30301780
28.

HCV core antigen as an alternative to HCV RNA testing in the era of direct-acting antivirals: retrospective screening and diagnostic cohort studies.

van Tilborg M, Al Marzooqi SH, Wong WWL, Maan R, Vermehren J, Maasoumy B, Mazzulli T, Bolotin S, Garber G, Guerra F, Flud CR, Kowgier M, Janssen HL, de Knegt RJ, Pawlotsky JM, Cloherty GA, Duarte-Rojo A, Sarrazin C, Wedemeyer H, Feld JJ.

Lancet Gastroenterol Hepatol. 2018 Dec;3(12):856-864. doi: 10.1016/S2468-1253(18)30271-1. Epub 2018 Sep 28.

PMID:
30274834
29.

Long-Term Effects of Treatment for Chronic HBV Infection on Patient-Reported Outcomes.

Younossi ZM, Stepanova M, Younossi I, Pan CQ, Janssen HLA, Papatheodoridis G, Nader F.

Clin Gastroenterol Hepatol. 2018 Sep 27. pii: S1542-3565(18)31073-5. doi: 10.1016/j.cgh.2018.09.041. [Epub ahead of print]

PMID:
30268565
30.

Breaking up sitting time after stroke (BUST-stroke).

English C, Janssen H, Crowfoot G, Callister R, Dunn A, Mackie P, Oldmeadow C, Ong LK, Palazzi K, Patterson AJ, Spratt NJ, Walker FR, Bernhardt J, Dunstan DW.

Int J Stroke. 2018 Dec;13(9):921-931. doi: 10.1177/1747493018801222. Epub 2018 Sep 18.

PMID:
30226448
31.

Frequent, short bouts of light-intensity exercises while standing decreases systolic blood pressure: Breaking Up Sitting Time after Stroke (BUST-Stroke) trial.

English C, Janssen H, Crowfoot G, Bourne J, Callister R, Dunn A, Oldmeadow C, Ong LK, Palazzi K, Patterson A, Spratt NJ, Walker FR, Dunstan DW, Bernhardt J.

Int J Stroke. 2018 Dec;13(9):932-940. doi: 10.1177/1747493018798535. Epub 2018 Sep 17.

PMID:
30223728
32.

Correction: Modelling of thermal transport through a nanocellular polymer foam: toward the generation of a new superinsulating material.

Wang G, Wang C, Zhao J, Wang G, Park CB, Zhao G, Van De Walle W, Janssen H.

Nanoscale. 2018 Nov 8;10(43):20469-20473. doi: 10.1039/c8nr90192a.

PMID:
30209498
33.

Elevated Presepsin Is Associated With Perioperative Major Adverse Cardiovascular and Cerebrovascular Complications in Elevated-Risk Patients Undergoing Noncardiac Surgery: The Leukocytes and Cardiovascular Perioperative Events Study.

Handke J, Scholz AS, Gillmann HJ, Janssen H, Dehne S, Arens C, Kummer L, Uhle F, Weigand MA, Motsch J, Larmann J.

Anesth Analg. 2018 Sep 5. doi: 10.1213/ANE.0000000000003738. [Epub ahead of print]

PMID:
30198925
34.
35.

Long-term follow-up of patients treated with entecavir and peginterferon add-on therapy for HBeAg-positive chronic hepatitis B infection: ARES long-term follow-up.

van Campenhout MJH, Brouwer WP, Xie Q, Guo S, Chi H, Qi X, Tabak F, Streinu-Cercel A, Wang JY, Zhang NP, Idilman R, Reesink HW, Diculescu M, Simon K, Akdogan M, Mazur W, de Knegt RJ, Verhey E, Hansen BE, Janssen HLA; ARES Study Group.

J Viral Hepat. 2019 Jan;26(1):109-117. doi: 10.1111/jvh.12997. Epub 2018 Sep 27.

PMID:
30187612
36.

Simtuzumab for Primary Sclerosing Cholangitis: Phase 2 Study Results With Insights on the Natural History of the Disease.

Muir AJ, Levy C, Janssen HLA, Montano-Loza AJ, Shiffman ML, Caldwell S, Luketic V, Ding D, Jia C, McColgan BJ, McHutchison JG, Mani Subramanian G, Myers RP, Manns M, Chapman R, Afdhal NH, Goodman Z, Eksteen B, Bowlus CL; GS-US-321-0102 Investigators.

Hepatology. 2019 Feb;69(2):684-698. doi: 10.1002/hep.30237. Epub 2019 Jan 11.

PMID:
30153359
37.

Comparison of brachytherapy and external beam radiotherapy boost in breast-conserving therapy: Patient-reported outcome measures and aesthetic outcome.

Kindts I, Laenen A, Christiaens M, Janssen H, Van Limbergen E, Weltens C.

Strahlenther Onkol. 2019 Jan;195(1):21-31. doi: 10.1007/s00066-018-1346-7. Epub 2018 Aug 23.

PMID:
30140943
38.

Heterogeneity of Network Structures and Water Dynamics in κ-Carrageenan Gels Probed by Nanoparticle Diffusometry.

de Kort DW, Schuster E, Hoeben FJM, Barnes R, Emondts M, Janssen HM, Lorén N, Han S, Van As H, van Duynhoven JPM.

Langmuir. 2018 Sep 18;34(37):11110-11120. doi: 10.1021/acs.langmuir.8b01052. Epub 2018 Sep 6.

39.

Impact of Comorbidities and Smoking on the Outcome in Aneurysmal Subarachnoid Hemorrhage.

Hammer A, Steiner A, Ranaie G, Yakubov E, Erbguth F, Hammer CM, Killer-Oberpfalzer M, Steiner H, Janssen H.

Sci Rep. 2018 Aug 17;8(1):12335. doi: 10.1038/s41598-018-30878-9.

40.

Severe Positional Central Sleep Apnea in an Asymptomatic Adult With a PHOX2B Frameshift Mutation.

Janssen HCJP, Vulto-van Silfhout AT, Jongmans MCJ, van der Hout AH, Overeem S.

J Clin Sleep Med. 2018 Aug 15;14(8):1427-1430. doi: 10.5664/jcsm.7290.

41.

Association of dietary macronutrient composition and non-alcoholic fatty liver disease in an ageing population: the Rotterdam Study.

Alferink LJ, Kiefte-de Jong JC, Erler NS, Veldt BJ, Schoufour JD, de Knegt RJ, Ikram MA, Metselaar HJ, Janssen H, Franco OH, Darwish Murad S.

Gut. 2018 Jul 31. pii: gutjnl-2017-315940. doi: 10.1136/gutjnl-2017-315940. [Epub ahead of print]

PMID:
30064987
42.

Activity monitors for increasing physical activity in adult stroke survivors.

Lynch EA, Jones TM, Simpson DB, Fini NA, Kuys SS, Borschmann K, Kramer S, Johnson L, Callisaya ML, Mahendran N, Janssen H, English C; ACTIOnS Collaboration.

Cochrane Database Syst Rev. 2018 Jul 27;7:CD012543. doi: 10.1002/14651858.CD012543.pub2. Review.

PMID:
30051462
43.

The development and validation of magnetic resonance elastography for fibrosis staging in primary sclerosing cholangitis.

Jhaveri KS, Hosseini-Nik H, Sadoughi N, Janssen H, Feld JJ, Fischer S, Menezes R, Cheung AC.

Eur Radiol. 2019 Feb;29(2):1039-1047. doi: 10.1007/s00330-018-5619-4. Epub 2018 Jul 26.

PMID:
30051141
44.

microRNA-19a-3p promotes tumor metastasis and chemoresistance through the PTEN/Akt pathway in hepatocellular carcinoma.

Jiang XM, Yu XN, Liu TT, Zhu HR, Shi X, Bilegsaikhan E, Guo HY, Song GQ, Weng SQ, Huang XX, Dong L, Janssen HLA, Shen XZ, Zhu JM.

Biomed Pharmacother. 2018 Sep;105:1147-1154. doi: 10.1016/j.biopha.2018.06.097. Epub 2018 Jun 21.

PMID:
30021351
45.

Neutrophils Kill Antibody-Opsonized Cancer Cells by Trogoptosis.

Matlung HL, Babes L, Zhao XW, van Houdt M, Treffers LW, van Rees DJ, Franke K, Schornagel K, Verkuijlen P, Janssen H, Halonen P, Lieftink C, Beijersbergen RL, Leusen JHW, Boelens JJ, Kuhnle I, van der Werff Ten Bosch J, Seeger K, Rutella S, Pagliara D, Matozaki T, Suzuki E, Menke-van der Houven van Oordt CW, van Bruggen R, Roos D, van Lier RAW, Kuijpers TW, Kubes P, van den Berg TK.

Cell Rep. 2018 Jun 26;23(13):3946-3959.e6. doi: 10.1016/j.celrep.2018.05.082.

46.

Spermine oxidase is upregulated and promotes tumor growth in hepatocellular carcinoma.

Hu T, Sun D, Zhang J, Xue R, Janssen HLA, Tang W, Dong L.

Hepatol Res. 2018 Nov;48(12):967-977. doi: 10.1111/hepr.13206. Epub 2018 Jul 27.

PMID:
29923661
47.

Serum Level of Antibodies Against Hepatitis B Core Protein Is Associated With Clinical Relapse After Discontinuation of Nucleos(t)ide Analogue Therapy.

Chi H, Li Z, Hansen BE, Yu T, Zhang X, Sun J, Hou J, Janssen HLA, Peng J.

Clin Gastroenterol Hepatol. 2019 Jan;17(1):182-191.e1. doi: 10.1016/j.cgh.2018.05.047. Epub 2018 Jun 11.

PMID:
29902645
48.

Microarray Expression Profiling of microRNAs Reveals Potential Biomarkers for Hepatocellular Carcinoma.

Zhu HR, Huang RZ, Yu XN, Shi X, Bilegsaikhan E, Guo HY, Song GQ, Weng SQ, Dong L, Janssen HLA, Shen XZ, Zhu JM.

Tohoku J Exp Med. 2018 Jun;245(2):89-98. doi: 10.1620/tjem.245.89.

49.

Weibel-Palade Body Localized Syntaxin-3 Modulates Von Willebrand Factor Secretion From Endothelial Cells.

Schillemans M, Karampini E, van den Eshof BL, Gangaev A, Hofman M, van Breevoort D, Meems H, Janssen H, Mulder AA, Jost CR, Escher JC, Adam R, Carter T, Koster AJ, van den Biggelaar M, Voorberg J, Bierings R.

Arterioscler Thromb Vasc Biol. 2018 Jul;38(7):1549-1561. doi: 10.1161/ATVBAHA.117.310701. Epub 2018 Jun 7.

50.

Hepatitis B virus infection.

Yuen MF, Chen DS, Dusheiko GM, Janssen HLA, Lau DTY, Locarnini SA, Peters MG, Lai CL.

Nat Rev Dis Primers. 2018 Jun 7;4:18035. doi: 10.1038/nrdp.2018.35. Review.

PMID:
29877316

Supplemental Content

Loading ...
Support Center